chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving Tdap patient experienced redness at site and headache.  While removing band-aid she scratched the scab off injection site with her nail and consequently developed redness, warmth, and tenderness at injection site.  Patient was treated for cellulitis with doxycycline 100mg PO BID for 10 days.  Will monitor injection site for increased signs and symptoms.
I started with a scratchy throat on 12/31/2022, which got worse. It was pretty sore for a couple of days. That seemed to subside, and then I had a fever on 1/1/2023. I pretty much had a fever for the whole time I was sick. At one point, it got up to 104 degrees. Prior to this, I had not taken anything, because my fever had been about 102. When it was 104, though, I took TYLENOL, which brought it down. On 1/3/2023, I took a home test and got a positive result. I was also very congested. On 1/5/2023, my temperature was 101. On 1/6/2023, I saw a PA. At this point, I was still testing positive. I explained my symptoms to the PA, who examined my ears, nose, and throat. I also had a cough, so he listened to my chest, as well. On that day, my temperature was 97.5. He advised me to stay hydrated, rest, use a humidifier, and take TYLENOL as needed. If I got worse, I was to contact them. He prescribed me a codeine cough syrup, but I didn't use it very long. I started feeling better, though I was still very tired. Altogether, I wasn't myself for about ten days, but I rebounded very quickly. I normally exercise every day, and I was able to resume that after my recovery. I had no lingering effects.
Local reactions back to back; This spontaneous case was received on 17-Dec-2020 from other non-health professional (consumer) via Med Communications (reference number: SEQW20-05827) and concerned a patient of unreported age and gender.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine, subunit influenza virus vaccine polyvalent; dose, route of administration and anatomical location: not reported) for influenza prophylaxis. The batch number reported was 279847, expiration date: 30-Jun-2021.  On an unspecified date, an unknown amount of time after receiving Flucelvax Quadrivalent, the patient developed local reactions back to back. It was not reported whether the patient received any corrective treatment.    The outcome of the event was unknown.  The reporter did not provide causality assessment.  The case is linked to the cases 202007727, 202007729 and 202007730 (the same reporter).  Company comment:The patient was vaccinated with the suspect product, Flucelvax Quadrivalent. On an unspecified date and unknown amount of time after receiving vaccine, the patient developed local reaction. Chronology is unclear. More information regarding temporal relationship, concomitant medications and underlying medical history is needed. Causality is assessed as unassessable due to lack of information.; Sender's Comments: The patient was vaccinated with the suspect product, Flucelvax Quadrivalent. On an unspecified date and unknown amount of time after receiving vaccine, the patient developed local reaction. Chronology is unclear. More information regarding temporal relationship, concomitant medications and underlying medical history is needed. Causality is assessed as unassessable due to lack of information.
Patient works at store. Returned 30 minutes after receiving vaccine with son (also an employee working) and said her ears and forhead were itching. Patient had no labored breathing, no hives, no redness, no swelling. Patient was speaking clearly and fluently  with me. Gave patient 50 mg diphenhydramine liquid and patient sat for a period of time. She wanted to return to work but I informed manager that patient would be leaving. Spouse picked patient and son up. Patient said she felt fine at that time. Called patient at 3:44 PM to check on her. Said she felt fine. Nothing reported to me after that.
On 3/28/21 I decided to get the Covid vaccine ?PFIZER ER8733 after my first dose I started to have joint pain in my left foot of which I thought was the onset of a gout attack. I increased my intake of POM juice and it did not make much of a difference and really no difference at all. I treated the pain with Motrin IB 200mg, four or more pills at a time or whatever was needed to relieve the pain, the pain never went away. I received my second dose of the PFIZER 0162 vaccine on 4/18/21 and then the pain and swelling attacked my left ankle and foot and the pain became unbearable. ?I was in tears? could barely walk and thought it was a gout attack. Unbearable pain!!!!!
experienced a severe lower back spasm; allergic reaction; chills; couldn't breathe, difficulty in breathing; became extremely flushed; feel very itchy; vomiting; ache; Initial information received on 04-Feb-2021 regarding an unsolicited valid non-serious case from a non-healthcare professional.  This case involves a 69 years old female patient who had a severe lower back spasm (muscle spasms), allergic reaction (hypersensitivity), chills, couldn't breathe, had difficulty in breathing (dyspnoea), became extremely flushed (flushing), feel very itchy (pruritus), vomiting, ache (pain), after receiving INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past vaccination(s) included with standard dose of INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant medication(s), and family history were not provided.  At the time of the event, the patient had ongoing hypersensitivity to some medicines and nuts.  On an unknown date in October 2019, the patient received dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [lot number: UJ235AB and expiry date not reported] via intramuscular route in an unknown administration site for prophylactic vaccination.  On an unknown date in October 2019, the patient developed a non-serious severe lower back spasm (muscle spasms), allergic reaction (hypersensitivity), chills, couldn't breathe, difficulty in breathing (dyspnoea), extremely flushed (flushing) (on the same day), feel very itchy (pruritus), vomiting, ache (pain) (Unknown latency), following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  No laboratory data reported.  The patient was treated by an emergency medical technician (EMT) for hypersensitivity, dyspnoea, flushing, muscle spasms and DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL TOTAL) for pruritus.  The patient recovered from hypersensitivity, dyspnoea, flushing, muscle spasms,as it is reported that patient started feeling better and her vital signs for reactions were fine, while the outcome is unknown for chills, pruritus, pain.
Patient received the flu vaccine on 10/18/2017. Two weeks later, patient reports coming down with a cold. She went to the Clinic (11/12) and then followed up with her PCP. She was referred to another physician as her symptoms were intensifying. Patient reports blurred vision, muscle weakness and feeling dizzy. She was admitted to the hospital (11/13) overnight patient reports that she has been diagnosed with Guillain Barre syndrome. Patient was told that the syndrome can last 4 to 6 weeks. After hospitalization, patient reports recovering at home.
pt recvd vax 16DEC92 AM & that PM leg sore, t101 & had crying episode lasting @ least 3+ hrs; cranky next day; OK  18-20DEC crying for 2 hrs off & on both days; took to MD 21DEC to make sure no OM & was OK;
Patient said she had a huge fear of needles and after both shots were given when she got up she became high headed and passed out. She became alert within a few seconds.
Diagnosis = Chronic Sinusitis/Rhinitis; 6 months time course; extreme discomfort Followed by Palindromic Rheumatism
Muscle cramping/pain in both knees suddenly a few days after first shot. Seemed to get better prior to 2nd shot but never went away. Left leg finally normalized a few weeks after 2nd shot but right leg pain worsened and spread down to my calf and up to my hamstring. Extreme pain/cramping began 10/9. Can?t step up on right leg at all. Pain intensifies after sitting too long, standing too long, driving, and laying down.
Difficulty of Breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty of Breathing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZOA) for COVID-19 vaccination.     Concurrent medical conditions included Clotting disorder and Kidney disorder. Concomitant products included METOPROLOL TARTRATE (LOPRESSOR), ZINC, APIXABAN (ELIQUIS) and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DYSPNOEA (Difficulty of Breathing). At the time of the report, DYSPNOEA (Difficulty of Breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Swelling from elbow to arm pit. Headache. Severe hot flashes followed by chills. All on going five weeks later.
This literature-non-study case was reported in a literature article and describes the occurrence of ENDOCRINE OPHTHALMOPATHY (TED reactivation) in a 66-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. LITERATURE REFERENCE: Thyroid eye disease reactivation associated with COVID-19 vaccination. The patient's past medical history included Thyroid eye disease. On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ENDOCRINE OPHTHALMOPATHY (seriousness criterion medically significant). At the time of the report, ENDOCRINE OPHTHALMOPATHY was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Thyroid function test: stable (normal) Stable. For mRNA-1273 (Spikevax) (Unknown), the reporter considered ENDOCRINE OPHTHALMOPATHY to be related. Three female patients over 18 years of age (range 4566 years) received either the Moderna or Pfizer COVID-19 vaccine presented with symptoms of thyroid eye disease within 24 h to 21 days of receiving their first or second dose. None of the patients had previous infections with severe acute respiratory syndrome coronavirus 2. All three patients presented with proptosis. In two of three patients, periorbital edema, eyelid retraction, and diplopia were present. None were current smokers. One had prior facial hyaluronic acid filler injections. Symptoms in all patients were improving at 4 to 8 months. Concomitant medication and treatment information were not reported by the reporter. Company comment: This literature non-study case concerns a 66-year-old female patient with medical history of Thyroid eye disease, who experienced the serious, due to medically significant, unexpected event of Endocrine Ophthalmopathy, which occurred 3 weeks after the 2nd dose of mRNA-1273 vaccine. No further information regarding the clinical course and treatment of the events were provided. The mentioned medical history remains as confounder for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report. This case was linked to MOD-2022-538891 (Patient Link). Sender's Comments: This literature non-study case concerns a 66-year-old female patient with medical history of Thyroid eye disease, who experienced the serious, due to medically significant, unexpected event of Endocrine Ophthalmopathy, which occurred 3 weeks after the 2nd dose of mRNA-1273 vaccine. No further information regarding the clinical course and treatment of the events were provided. The mentioned medical history remains as confounder for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Soreness; Fatigue; Shivering; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain, fatigue and shivering. On an unknown date, the outcome of the pain, fatigue and shivering were not recovered/not resolved.   It was unknown if the reporter considered the pain, fatigue and shivering to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient wanted to know how long did the mild side effects like soreness, fatigue and shivering tend to last after 2nd dose of vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 05Jul2022 at 10:00 as dose 4 (booster), single (Lot number: Fm7553) at the age of 50 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "DM" (unspecified if ongoing), notes: controlled, not on DM meds. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Based on the information currently available, a causal association between the reported event and BNT162b2 cannot be excluded.
Expiration date was 04/10/2023 after leaving ultraviolet freezer.
Narrative: 56 y/o pt received first dose of Pfizer COVID-19 vaccine on 3/12. Pt expired 4/6.
Flu; Bleeding; This spontaneous case was reported by a pharmacist and describes the occurrence of INFLUENZA (Flu) and HEAVY MENSTRUAL BLEEDING (Bleeding) in a 45-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 060f22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 06-Oct-2022, the patient experienced HEAVY MENSTRUAL BLEEDING (Bleeding). On an unknown date, the patient experienced INFLUENZA (Flu). At the time of the report, INFLUENZA (Flu) and HEAVY MENSTRUAL BLEEDING (Bleeding) was resolving.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicine were reported. No treatment medicine were reported.
My husband fell in the bathroom about 4am. I popped out of bed to see what happened. Within 2 minutes I got extremely dizzy and sick to my stomach.  I broke out in a cold sweat; I sweat through all my night clothes. I sat on the commode to use the bathroom. I put my head between my knees to try to control the dizziness. Next thing I know I am lying on the floor. I got back up; I was still dizzy. I had to put my head down on the vanity. It took several minutes before the dizziness and queazy stomach backed off. At some point I had to use the bathroom again, at which time I had diarrhea.  My husband said he saw me fall off commode. He said my name several times before I responded. I asked my husband (what had happened to him. He said he got dizzy; next thing he knew he was on the floor in extreme pain in his shoulder, arm and ribs. It took us probably another 15 min. to figure out how to get him off the floor. I cannot lift him as he is twice my size. He was finally able to do work his way up off the floor. We got back to the bed. I dozed a couple of hours before getting up at 7. We went to the Hospital ER for treatment about 10am.  I continued to have that slight head rush feeling on and off for the next 3 days.
Second dose administered in the left arm on 3/12/21 was spilled due to a loosely fastened syringe. Pharmacist  claims <1/2 dose may have entered his arm. The full dose was repeated in the opposite arm (right) on 3/17/21. Patient will monitor for side effects.
Pt called 10-10-12. Said he had a shingles shot on 10-8-12 and had a swollen place on back of his arm the size of a lemon. No pain or itching at site. Recommended him call MD & to take BENADRYL & ice the site.
Patient received her first  felt poorly for weeks after the first Covid 19 vaccine on 3/19/2021.She recovered enough for the second dose. After that she did not recover. Dysautonomia symptoms, chest pain, heart pulpitatibrain, heart rate fluctuating between lower 40s to 160s, shortness of breath and tremors after mild excertion, extreme low blood pressure, fog, swelling of legs when standing, feeling very ill, insomnia, interrupted sleeping pattern, extreme fatigue, Small muscle spasms & sudden reflex sending electric shock waves through body leaving a tingly sensation behind. For months light touch was irritating or painful as this became less of a problem joint pains started.
Information has been received from a pharmacist referring to 3 newborns. Background: Since June 2015, there had been 1645 times (30 minutes each time= 822.5 hours) that the temperature dropped below 36F. Of course, there was 144 times (30 minutes each time=72 hours) that temperature was below 32F, the lowest being 29.7F. On 04-JUL-2015, there was a low temperature of 30.2F. On 13-SEP-2015 the patients were vaccinated with the improperly stored RECOMBIVAX HB strength 2.5/0.5 (units not provided) (lot number K020216 and expiration date of 17-SEP-2016) (dose and route of administration were not reported). There was no product quality complaint (PQC). This is one of several reports received from the same reporter. Additional information has been requested.
Pt reported adverse reaction to DT vaccine on 7/18/06. Pt stated she felt very fatigued, nausea, feverish. Disoriented as if she had a hangover. These symptoms lasted for 3 days. Started approx 1 hr after vaccine was given on 07/14/06 and lasted until late in day 7/18/06. Pt states she now feels fine.
After both Covid vaccines (first one on Feb 17, 2021) I got a pressure-headache that was present all the first and second day after and then subsided to intermittent every few days for about a week.  After the second vaccine, I've also had daily occular-migraines and.or light-sensitivity/auras for week2-post-vaccine (from about Mar 25 to Apr 1).   In my younger years, I experienced occular migraines from time to time but usually for not more than one day,  and only one or two per year.  After going through menopause 8 years ago, such migraines ceased, until this recent round post-vaccine and persisting daily.
One week prior to third dose of Lymerix the pt experienced a tick bite in his right groin area. The ELISA test was positive, Western blot overall was positive and some IgG antibodies were negative. Pt was treated with doxycycline for 3 weeks. The most recent information reports the outcome of the event as ongoing.
rigors, severe muscle aches and headache  for 18-24 hours, requiring 1 day of missed work
Starting within 24 hours after receiving the vaccine, I developed severe pain at the injection site, overall aches/pains, chills and felt feverish. My armpit lymph node became enlarged, swollen and very painful. This lasted for about 3-4 days. Overall aches/chills lasted for about 24 hours then resolved. The arm pain lasted for about 5 days then resolved.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Dec-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.
Patient received the Pfizer-BioNtech Covid-19 vaccine EUA on 1/25/21 at 2:10 pm. Approximately 30 minutes following the vaccine , the patient began to experience tachycardia. Patient's vitals assessed. At 2:40 pm, B/P 130/80, HR 124, O2 % 99 at room air. Patient seemed to be anxious during this time. Patient provided a bottle of water and remained seated for 10 minutes. Vitals re-checked at 2:50 pm, B/P 130/86, HR 116, O2 % 99 room air. Vitals re-checked at 3:05 pm, B/P 112/80, HR 112, O2 % 98 at room air. Patient stated that she is currently on cardiac medication and has an appointment with her cardiologist on wednesday. Patient stated that she was feeling fine and wanted to leave.
Swollen lips, discomfort around swelling. Swelling lasted ~3 hrs. After swelling resolved, general itchiness all over body.
On 9/29/00, the pt received his 5th, left arm, dose of Infanrix. The pt's mother stated that 2 days later, on 10/01/00, the vaccinee developed a red, hot, purple rash below the injection site. The vaccinee did not complain of pain; the site was swollen. On 10/6/00, the pt experienced multiple hives in various sizes on the left arm only below the injection site which blanched with pressure. No itching or fever was noted. A doctor visit was required and the pt was treated with diphenhydramine hydrochloride 12.5mg every 6 hours. As of 11/2/00, the outcome of the event is unknown.
I have had Migraines all my life but since I got my COVID-19 vaccine I have been having more frequent and more severe migraines as well as problems with focus. It has been nine months and I have lost a lot of work. My migraines are triggered by smaller headaches which start. I am seeing a Neurologist and I have had an MRI. The headaches started about 3 months after getting the second dose of the vaccine. My migraines were controlled before and only happened a couple of times a month. They were easily controlled with medication. I started to get migraines 10-12 times a month and they are not easily controlled with medication. I was prescribed Inderal and I have to take 120mg as well as the medication that I used to take. Sometimes the medication does not work. I have extreme fatigue all the time and trouble focusing at work. I have had a lot of medication changes with no improvement. The headaches start at the back of my head and then move toward the front. My migraines were normally on the right side of my face and my jaw would ache. These are totally different, and they last for days sometimes. I have gone to Urgent Care and to the ER because the pain is out of control.